{"id":783693,"date":"2023-09-13T07:24:52","date_gmt":"2023-09-13T11:24:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\/"},"modified":"2023-09-13T07:24:52","modified_gmt":"2023-09-13T11:24:52","slug":"helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\/","title":{"rendered":"Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference"},"content":{"rendered":"
\n

— Presentation to educate on Portable Neuromodulation Stimulator (PoNS\u00ae<\/sup>) Therapy, highlighting the differentiation from other neuromodulation technologies, and the science behind its effectiveness, clinical data, safety profile —<\/p>\n

— Forum brings together world experts from the core disciplines of clinical neurosciences and rehabilitation —<\/p>\n

NEWTOWN, Pa., Sept. 13, 2023 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (\u201cHelius\u201d or the \u201cCompany\u201d), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that Antonella Favit-Van Pelt, M.D., Ph.D., Helius\u2019 Chief Medical Officer, will present at the Interdisciplinary Association of Neuroscience and Rehabilitation\u00a0(IAFNR<\/a>) Conference from September 28 to October 1, 2023. The IAFNR Conference is a four-day virtual event intended for neuroscience experts, including movement and neuromuscular disorder specialists, physical therapists, and occupational therapists.<\/p>\n

\u201cIt is a privilege to inform this prestigious group of clinical neuroscientists and innovators in the field of rehabilitation on the mechanistic basis and clinical outcome evidence for PoNS therapeutic benefit in gait or balance rehabilitation for people with traumatic brain injury, stroke, or multiple sclerosis,\u201d said Dr. Favit-Van Pelt. \u201cThe field of neuromodulation-based healthcare is evolving rapidly, and we believe that PoNS Therapy\u2122\u00a0is a groundbreaking treatment for people suffering from balance or gait impairment. Our goal has always been to bring this impactful technology to as many qualifying patients as possible, and this forum is an excellent platform to create awareness and engage leading practitioners in neurorehabilitation.\u201d<\/p>\n

Details of the presentation are as follows:<\/p>\n\n\n\n\n\n\n
\n Presentation:<\/strong>\n <\/td>\nSustained Neuromodulation Leads to Long Term Neuroplasticity for Balance and Gait Rehabilitation<\/td>\n<\/tr>\n
\n Date:<\/strong>\n <\/td>\nSaturday, September 30<\/td>\n<\/tr>\n
\n Time:<\/strong>\n <\/td>\n5:00PM<\/td>\n<\/tr>\n
\n Event Registration:<\/strong>\n <\/td>\n\n
\n Click Here<\/strong>
\n <\/a>\n <\/td>\n<\/tr>\n
\n Webcast:<\/strong>\n <\/td>\n\n
\n Click Here<\/strong>
\n <\/a>\n <\/td>\n<\/tr>\n<\/table>\n

\n About Helius Medical Technologies, Inc.<\/strong>\u00a0<\/p>\n

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain\u2019s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. The Company\u2019s first commercial product is the Portable Neuromodulation Stimulator (PoNS\u00ae) device. For more information about the PoNS\u00ae or Helius Medical Technologies, visit www.heliusmedical.com<\/u><\/a>.\u00a0\u00a0<\/p>\n

\n About the PoNS Device and PoNS Therapy<\/strong>\u00a0<\/p>\n

The Portable Neuromodulation Stimulator (PoNS) is an innovative, non-implantable, orally applied therapy that delivers neurostimulation through a mouthpiece connected to a controller and it\u2019s used, primarily at home, with physical rehabilitation exercise, to improve balance and gait. The PoNS device, which delivers mild electrical impulses to the tongue, is indicated for use in the United States as a short-term treatment of gait deficit due to mild-to-moderate symptoms from multiple sclerosis (\u201cMS\u201d) and is to be used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.\u00a0<\/p>\n

PoNS has shown effectiveness in treating gait or balance and a significant reduction in the risk of falling in stroke patients in Canada, where it received authorization for sale in three indications: (i) for use as a short-term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from stroke and is to be used in conjunction with physical therapy; (ii) for use as a short-term treatment (14 weeks) of chronic balance deficit due to mild-to-moderate traumatic brain injury (\u201cmmTBI\u201d) and is to be used in conjunction with physical therapy; and (iii) for use as a short-term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from MS and is to be used in conjunction with physical therapy. PoNS is also authorized for sale in Australia for short term use by healthcare professionals as an adjunct to a therapeutic exercise program to improve balance and gait. For more information visit\u202fwww.ponstherapy.com<\/u><\/a> or www.ponstherapy.ca<\/a>.<\/p>\n

\n Cautionary Disclaimer Statement<\/strong>\n <\/p>\n

Certain statements in this news release are not based on historical facts and constitute forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities laws. All statements other than statements of historical fact included in this news release are forward-looking statements that involve risks and uncertainties. Forward-looking statements are often identified by terms such as \u201cbelieve,\u201d \u201cexpect,\u201d \u201ccontinue,\u201d \u201cwill,\u201d \u201cgoal,\u201d \u201caim\u201d and similar expressions. Such forward-looking statements include, among others, statements regarding the uses and effectiveness of PoNS and PoNS Therapy.\u00a0<\/p>\n

There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those expressed or implied by such statements. Important factors that could cause actual results to differ materially from the Company\u2019s expectations include uncertainties associated with the Company\u2019s capital requirements to achieve its business objectives, disruptions in the banking system and financial markets, lingering impacts of the COVID-19 pandemic, the effect of macroeconomic conditions and the Company\u2019s ability to access capital markets, the Company\u2019s ability to train physical therapists in the supervision of the use of the PoNS Treatment, the Company\u2019s ability to secure contracts with rehabilitation clinics, the Company\u2019s ability to obtain national Medicare coverage and to obtain a reimbursement code so that the PoNS device is covered by Medicare and Medicaid, the Company\u2019s ability to build internal commercial infrastructure, secure state distribution licenses, build a commercial team and build relationships with Key Opinion Leaders, neurology experts and neurorehabilitation centers, market awareness of the PoNS device, availability of funds, manufacturing, labor shortage and supply chain risks, our ability to maintain and enforce our intellectual property rights, clinical trials and the clinical development process, the product development process, the regulatory submission review and approval process, our operating costs and use of cash, and our ability to achieve significant revenues, ongoing government regulation, and other risks detailed from time to time in the \u201cRisk Factors\u201d section of the Company\u2019s Annual Report on Form 10-K for the year ended December 31, 2022, and its other filings with the United States Securities and Exchange Commission and the Canadian securities regulators, which can be obtained from either at www.sec.gov or www.sedar.com.\u00a0<\/p>\n

The reader is cautioned not to place undue reliance on any forward-looking statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company assumes no obligation to update any forward-looking statement or to update the reasons why actual results could differ from such statements except to the extent required by law.\u00a0<\/p>\n

\n Investor Relations Contact<\/strong>\u00a0
Lisa M. Wilson, In-Site Communications, Inc.\u00a0
T: 212-452-2793\u00a0
E: lwilson@insitecony.com<\/a>\u00a0<\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

— Presentation to educate on Portable Neuromodulation Stimulator (PoNS\u00ae) Therapy, highlighting the differentiation from other neuromodulation technologies, and the science behind its effectiveness, clinical data, safety profile — — Forum brings together world experts from the core disciplines of clinical neurosciences and rehabilitation — NEWTOWN, Pa., Sept. 13, 2023 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (\u201cHelius\u201d or the \u201cCompany\u201d), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that Antonella Favit-Van Pelt, M.D., Ph.D., Helius\u2019 Chief Medical Officer, will present at the Interdisciplinary Association of Neuroscience and Rehabilitation\u00a0(IAFNR) Conference from September 28 to October 1, 2023. The IAFNR Conference is a four-day virtual event intended for neuroscience experts, including … <\/p>\n

Continue reading “Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-783693","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nHelius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"— Presentation to educate on Portable Neuromodulation Stimulator (PoNS\u00ae) Therapy, highlighting the differentiation from other neuromodulation technologies, and the science behind its effectiveness, clinical data, safety profile — — Forum brings together world experts from the core disciplines of clinical neurosciences and rehabilitation — NEWTOWN, Pa., Sept. 13, 2023 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (\u201cHelius\u201d or the \u201cCompany\u201d), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that Antonella Favit-Van Pelt, M.D., Ph.D., Helius\u2019 Chief Medical Officer, will present at the Interdisciplinary Association of Neuroscience and Rehabilitation\u00a0(IAFNR) Conference from September 28 to October 1, 2023. The IAFNR Conference is a four-day virtual event intended for neuroscience experts, including … Continue reading "Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-13T11:24:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMDgzNCM1ODEwNjA2IzIwODIwMzE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference\",\"datePublished\":\"2023-09-13T11:24:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\\\/\"},\"wordCount\":1086,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMDgzNCM1ODEwNjA2IzIwODIwMzE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\\\/\",\"name\":\"Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMDgzNCM1ODEwNjA2IzIwODIwMzE=\",\"datePublished\":\"2023-09-13T11:24:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMDgzNCM1ODEwNjA2IzIwODIwMzE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMDgzNCM1ODEwNjA2IzIwODIwMzE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\/","og_locale":"en_US","og_type":"article","og_title":"Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference - Market Newsdesk","og_description":"— Presentation to educate on Portable Neuromodulation Stimulator (PoNS\u00ae) Therapy, highlighting the differentiation from other neuromodulation technologies, and the science behind its effectiveness, clinical data, safety profile — — Forum brings together world experts from the core disciplines of clinical neurosciences and rehabilitation — NEWTOWN, Pa., Sept. 13, 2023 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (\u201cHelius\u201d or the \u201cCompany\u201d), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that Antonella Favit-Van Pelt, M.D., Ph.D., Helius\u2019 Chief Medical Officer, will present at the Interdisciplinary Association of Neuroscience and Rehabilitation\u00a0(IAFNR) Conference from September 28 to October 1, 2023. The IAFNR Conference is a four-day virtual event intended for neuroscience experts, including … Continue reading \"Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-13T11:24:52+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMDgzNCM1ODEwNjA2IzIwODIwMzE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference","datePublished":"2023-09-13T11:24:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\/"},"wordCount":1086,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMDgzNCM1ODEwNjA2IzIwODIwMzE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\/","name":"Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMDgzNCM1ODEwNjA2IzIwODIwMzE=","datePublished":"2023-09-13T11:24:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMDgzNCM1ODEwNjA2IzIwODIwMzE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMDgzNCM1ODEwNjA2IzIwODIwMzE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-2023-interdisciplinary-association-of-functional-neuroscience-and-rehabilitation-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/783693","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=783693"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/783693\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=783693"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=783693"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=783693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}